Featured
Malaria vaccine: 77% efficacy
EDCTP-funded phase II clinical trial in Burkina Faso demonstrates that malaria vaccine candidate R21/Matrix-M is safe, immunogenic and has an efficacy of 77%.
10th EDCTP Forum - Call for abstracts
The hybrid 10th EDCTP Forum 'Equity in Research for Health' will take place from 17-20 October 2021.
The call for abstracts is now open! Deadline: 12 June 2021.
EDCTP Update April 2021
EDCTP’s monthly electronic newsletter | project news, events, funding and resources
Projects
Access our online projects database and guidance information to manage EDCTP2 grants.
Achievements
See our achievements in bringing together research from Europe and Africa and developing research capacity in sub-Saharan Africa.
News
04 May 2021
New support tools for TB vaccine R&D published
24 March 2021
World TB Day: the promise of ending the TB epidemic
Latest Tweets
RT @KCRITanzania: Read our May newsletter here: https://t.co/2vqxvm9FSw #kcri #newletter #eapoc #panacea #seqtanzania @EACCR2 @EDCTP @Stell…See the post
1 day ago
RT @EACCR2: #EACCR:The training node located in Kilimanjaro christian medical centre in mosh TZ,condinates training $ mentoring activities…See the post
1 day ago
The ANTICOV clinical trial, conducted in 13 African countries, has started the recruitment of participants to test… https://t.co/bmupAAWZw1See the post
1 day ago